These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 30244390)

  • 1. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma.
    Michael Traeger M; Rehkaemper J; Ullerich H; Steinestel K; Wardelmann E; Senninger N; Abdallah Dhayat S
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2419-2431. PubMed ID: 30244390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA-99 family as liquid biopsy marker in pancreatic adenocarcinoma.
    Stroese AJ; Ullerich H; Koehler G; Raetzel V; Senninger N; Dhayat SA
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2377-2390. PubMed ID: 30225540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
    Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
    World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B; Liu X; Gao Y; Li L; Dong Z
    Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study.
    Jiang D; Yuan X; Ni J; Shen L; Cai M; Xu L
    Can J Gastroenterol Hepatol; 2021; 2021():8882129. PubMed ID: 34222137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of circulating LAPTM4B-35 in pancreatic ductal adenocarcinoma.
    Yang Z; Senninger N; Flammang I; Ye Q; Dhayat SA
    J Cancer Res Clin Oncol; 2019 May; 145(5):1165-1178. PubMed ID: 30778748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma.
    Khan IA; Rashid S; Singh N; Rashid S; Singh V; Gunjan D; Das P; Dash NR; Pandey RM; Chauhan SS; Gupta S; Saraya A
    Sci Rep; 2021 Feb; 11(1):2824. PubMed ID: 33531550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN.
    Xiong J; Wang D; Wei A; Lu H; Tan C; Li A; Tang J; Wang Y; He S; Liu X; Hu W
    Exp Cell Res; 2017 Dec; 361(2):316-323. PubMed ID: 29111166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma.
    Dhayat SA; Traeger MM; Rehkaemper J; Stroese AJ; Steinestel K; Wardelmann E; Kabar I; Senninger N
    Cancers (Basel); 2018 Sep; 10(9):. PubMed ID: 30217058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.
    Vila-Navarro E; Duran-Sanchon S; Vila-Casadesús M; Moreira L; Ginès À; Cuatrecasas M; Lozano JJ; Bujanda L; Castells A; Gironella M
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00029. PubMed ID: 31009404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294.
    Xu Y; Yao Y; Gao P; Cui Y
    Biochem Biophys Res Commun; 2019 Jan; 509(1):138-142. PubMed ID: 30591218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing.
    Shen P; Yang T; Chen Q; Yuan H; Wu P; Cai B; Meng L; Huang X; Liu J; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
    Mol Cancer; 2021 Mar; 20(1):51. PubMed ID: 33750389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
    Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
    Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression.
    Guo S; Xu X; Tang Y; Zhang C; Li J; Ouyang Y; Ju J; Bie P; Wang H
    Cancer Lett; 2014 Mar; 344(1):40-46. PubMed ID: 24252251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma.
    Nesteruk K; Levink IJM; de Vries E; Visser IJ; Peppelenbosch MP; Cahen DL; Fuhler GM; Bruno MJ
    Pancreatology; 2022 Jun; 22(5):626-635. PubMed ID: 35613957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
    Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M
    Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting EMT.
    Yuan Q; Zhang Y; Feng L; Jiang Y
    J Cell Biochem; 2019 Jan; 120(1):552-561. PubMed ID: 30203487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.
    Long LM; Zhan JK; Wang HQ; Li S; Chen YY; Liu YS
    Pathobiology; 2017; 84(1):38-48. PubMed ID: 27458977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Serum miRNA Signature and Establishment of a Nomogram for Risk Stratification in Patients With Pancreatic Ductal Adenocarcinoma.
    Kandimalla R; Shimura T; Mallik S; Sonohara F; Tsai S; Evans DB; Kim SC; Baba H; Kodera Y; Von Hoff D; Chen X; Goel A
    Ann Surg; 2022 Jan; 275(1):e229-e237. PubMed ID: 32398486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.